Results 51 to 60 of about 159,299 (261)

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

The effectiveness of COVID-19 vaccines and the added benefit of booster doses in Hessen, Germany, during the COVID-19 pandemic: Results from a vaccinated-only study

Human Vaccines & Immunotherapeutics
Estimates of the added benefit from COVID-19 vaccine booster doses can inform seasonal vaccine recommendations. We set out to estimate COVID-19 vaccine effectiveness (VE), avoiding common sources of bias.
Ivo M. Foppa, Malin Trabold, Michael Frowein   +2 more
doaj   +1 more source

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

Vaccines, 2022
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups.
Claudia Maria Trombetta, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani, Serena Marchi   +4 more
doaj   +1 more source

Effectiveness Of The Pigeon Pox Vaccine On The Chicken Vaccinated With Avian Influenza Vaccine [PDF]

Journal of Applied Veterinary Sciences, 2019
Evaluation of the effectiveness of pigeon pox (PP) vaccine in improvement the required immunity to avian influenza (AI) virus vaccine in birds and reducing its shedding after challenge was the object of this study.Specific pathogen free chicks were vaccinated with PP and AI in 10 groups at 5 and/or 8 days of age and/or boosted after 35 days then ...
Christine A. Mikhael, Nada, A. Fathy
openaire   +1 more source

COVID‐19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans

Arthritis Care &Research, EarlyView.
Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández, Naomi Schlesinger, Jorge Rojas, Jessica A. Walsh, Tawnie J. Braaten, Gary A. Kunkel, Makoto Jones, Brian C Sauer, Julio Facelli, Grant W. Cannon, Dorota Lebiedz‐Odrobina   +10 more
wiley   +1 more source

Measles vaccine effectiveness in African children: a systematic review and meta-analysis

BMC Infectious Diseases
Introduction Measles is an extremely contagious viral disease that can be prevented through vaccination. It is caused by the measles virus and presents with symptoms such as high fever, cough, runny nose, conjunctivitis, and a distinctive rash ...
Demeke Endalamaw, Endalkachew Nibret, Abaineh Munshea, Feleke Mekonnen, Senait Tadesse, Taye Zeru, Mesfine Tefera, Gizachew Yismaw   +7 more
doaj   +1 more source

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

Human Vaccines & Immunotherapeutics
Chikungunya virus (CHIKV), transmitted through Aedes mosquitoes, is a significant global health concern. Various vaccine platforms have been explored to combat CHIKV, including formalin inactivation, live-attenuated strains, virus-like particles (VLPs ...
Ariel Bardach, Martin Brizuela, Mabel Berrueta, Agustín Ciapponi, Juan M. Sambade, Jamile Ballivian, Vanesa Ortega, Noelia Castellana, Daniel Comandé, Edward P. K. Parker, Beate Kampmann, Katharina Stegelmann, Xu Xiong, Andy Stergachis, Flor M. Munoz, Pierre Buekens, Agustina Mazzoni   +16 more
doaj   +1 more source

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021

BMC Medicine, 2022
Background COVID-19 vaccines have been crucial in the pandemic response and understanding changes in vaccines effectiveness is essential to guide vaccine policies.
Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, Lamprini Veneti, Sara Viksmoen Watle, Hinta Meijerink   +8 more
doaj   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source

Sociodemographic correlates of human papillomavirus and hepatitis B vaccination status in Canada: a cross-sectional study

BMJ Public Health
Introduction Human papillomavirus (HPV) and hepatitis B (HBV) vaccines are critical to cancer prevention strategies; however, achieving high vaccination coverage remains a challenge. We aimed to investigate the proportion of Canadian 14-year-old children
Ramandip Grewal, Gilla K Shapiro, Gwen Elizabeth Eyre, Tara Martin, Selma Osman, Julien Robitaille, Shelly Bolotin, Anna-maria Frescura   +7 more
doaj   +1 more source